Structural Elements Underlying the High Binding Affinity of Human Cytomegalovirus UL18 to Leukocyte Immunoglobulin-like Receptor-1

Journal of Molecular Biology

Volumn 373, Issue 3, 2007, Pages 695-705

  Wagner, Claudia S ^a   Rölle, Alexander ^b   Cosman, David ^c   Ljunggren, Hans Gustaf ^a   Berndt, Kurt D ^a,d   Achour, Adnane ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Strategic Research Center for Studies of Integrative Recognition in the Immune System   (Sweden)

^c AMGEN INC   (United States)

^d School of Life Sciences Södertörn University   (Sweden)

Author keywords

cytomegalovirus; human; ILT2 CD85j LILRB1; MHC class I; viral homologue

Indexed keywords

DISULFIDE; LEUKOCYTE IMMUNOGLOBULIN LIKE RECEPTOR 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UL18 ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; BINDING AFFINITY; BONE MARROW CELL; CONTROLLED STUDY; CRYSTAL STRUCTURE; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; LYMPHOID CELL; MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 34748843922     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.08.020     Document Type: Article

References (51)

1. Mocarski E.J.J. In: Knipe D.M., Griffin D.E., Lamb R.A., Martin M.A., Roizman B., and Strauss S.E. (Eds). Cytomegaloviruses and their Replication: Virology, 5th edit. vol. 2 (2006), Lippincott William & Wilkins, Philadelphia
2. Tortorella D., Gewurz B., Schust D., Furman M., and Ploegh H. Down-regulation of MHC class I antigen presentation by HCMV; lessons for tumor immunology. Immunol. Invest. 29 (2000) 97-100
3. Xu X.N., Screaton G.R., and McMichael A.J. Virus infections: escape, resistance, and counterattack. Immunity 15 (2001) 867-870
4. Tomasec P., Wang E.C., Davison A.J., Vojtesek B., Armstrong M., Griffin C., et al. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. Nature Immunol. 6 (2005) 181-188
5. Bacon L., Eagle R.A., Meyer M., Easom N., Young N.T., and Trowsdale J. Two human ULBP/RAET1 molecules with transmembrane regions are ligands for NKG2D. J. Immunol. 173 (2004) 1078-1084
6. Arnon T.I., Achdout H., Levi O., Markel G., Saleh N., Katz G., et al. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nature Immunol. 6 (2005) 515-523
7. Farrell H.E., Degli-Esposti M.A., and Davis-Poynter N.J. Cytomegalovirus evasion of natural killer cell responses. Immunol. Rev. 168 (1999) 187-197
8. Cosman D., Mullberg J., Sutherland C.L., Chin W., Armitage R., Fanslow W., et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14 (2001) 123-133
9. Tomasec P., Braud V.M., Rickards C., Powell M.B., McSharry B.P., Gadola S., et al. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287 (2000) 1031-1033
10. Chalupny N.J., Rein-Weston A., Dosch S., and Cosman D. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. Biochem. Biophys. Res. Commun. 346 (2006) 175-181
11. Wills M.R., Ashiru O., Reeves M.B., Okecha G., Trowsdale J., Tomasec P., et al. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. J. Immunol. 175 (2005) 7457-7465
12. Prod'homme V., Griffin C., Aicheler R.J., Wang E.C., McSharry B.P., Rickards C.R., et al. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1- NK cells. J. Immunol. 178 (2007) 4473-4481
13. Beck S., and Barrell B.G. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331 (1988) 269-272
14. Browne H., Smith G., Beck S., and Minson T. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 347 (1990) 770-772
15. Fahnestock M.L., Johnson J.L., Feldman R.M., Neveu J.M., Lane W.S., and Bjorkman P.J. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3 (1995) 583-590
16. Cosman D., Fanger N., Borges L., Kubin M., Chin W., Peterson L., and Hsu M.L. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. Immunity 7 (1997) 273-282
17. Leong C.C., Chapman T.L., Bjorkman P.J., Formankova D., Mocarski E.S., Phillips J.H., and Lanier L.L. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J. Exp. Med. 187 (1998) 1681-1687
18. Reyburn H.T., Mandelboim O., Vales-Gomez M., Davis D.M., Pazmany L., and Strominger J.L. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386 (1997) 514-517
19. Saverino D., Ghiotto F., Merlo A., Bruno S., Battini L., Occhino M., et al. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus-infected cells. J. Immunol. 172 (2004) 5629-5637
20. Vitale M., Castriconi R., Parolini S., Pende D., Hsu M.L., Moretta L., et al. The leukocyte Ig-like receptor (LIR)-1 for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles: analysis of LIR-1 + NK cell clones. Int. Immunol. 11 (1999) 29-35
21. Kim J.S., Choi S.E., Yun I.H., Kim J.Y., Ahn C., Kim S.J., et al. Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. Biochem. Biophys. Res. Commun. 315 (2004) 144-150
22. Odeberg J., Cerboni C., Browne H., Karre K., Moller E., Carbone E., and Soderberg-Naucler C. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. Scand. J. Immunol. 55 (2002) 149-161
23. Wagner C.S., Riise G.C., Bergstrom T., Karre K., Carbone E., and Berg L. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. J. Immunol. 178 (2007) 3536-3543
24. Colonna M., Navarro F., Bellon T., Llano M., Garcia P., Samaridis J., et al. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J. Exp. Med. 186 (1997) 1809-1818
25. Sayos J., Martinez-Barriocanal A., Kitzig F., Bellon T., and Lopez-Botet M. Recruitment of C-terminal Src kinase by the leukocyte inhibitory receptor CD85j. Biochem. Biophys. Res. Commun. 324 (2004) 640-647
26. Chapman T.L., Heikeman A.P., and Bjorkman P.J. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11 (1999) 603-613
27. Liang S., Zhang W., and Horuzsko A. Human ILT2 receptor associates with murine MHC class I molecules in vivo and impairs T cell function. Eur. J. Immunol. 36 (2006) 2457-2471
28. Navarro F., Llano M., Bellon T., Colonna M., Geraghty D.E., and Lopez-Botet M. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29 (1999) 277-283
29. Lepin E.J., Bastin J.M., Allan D.S., Roncador G., Braud V.M., Mason D.Y., et al. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur. J. Immunol. 30 (2000) 3552-3561
30. Willcox B.E., Thomas L.M., and Bjorkman P.J. Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor. Nature Immunol. 4 (2003) 913-919
31. Cerboni C., Achour A., Warnmark A., Mousavi-Jazi M., Sandalova T., Hsu M.L., et al. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j. Eur. J. Immunol. 36 (2006) 732-741
32. Chapman T.L., Heikema A.P., West Jr. A.P., and Bjorkman P.J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 13 (2000) 727-736
33. Salter R.D. Mutant HLA-A201 heavy chains with lowered affinity for beta 2m are transported after growth at reduced temperatures. Hum. Immunol. 35 (1992) 40-49
34. Dick T.P. Assembly of MHC class I peptide complexes from the perspective of disulfide bond formation. Cell Mol. Life Sci. 61 (2004) 547-556
35. Miyazaki J., Appella E., and Ozato K. Intracellular transport blockade caused by disruption of the disulfide bridge in the third external domain of major histocompatibility complex class I antigen. Proc. Natl Acad. Sci. USA 83 (1986) 757-761
36. Manavalan P., and Johnson W.C. Sensitivity of circular dichroism to protein tertiary structure class. Nature 305 (1983) 831-832
37. Gonen-Gross T., Achdout H., Arnon T.I., Gazit R., Stern N., Horejsi V., et al. The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules. J. Immunol. 175 (2005) 4866-4874
38. Allen R.L., Raine T., Haude A., Trowsdale J., and Wilson M.J. Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures. J. Immunol. 167 (2001) 5543-5547
39. Shiroishi M., Tsumoto K., Amano K., Shirakihara Y., Colonna M., Braud V.M., et al. Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl Acad. Sci. USA 100 (2003) 8856-8861
40. Achour A., Michaelsson J., Harris R.A., Ljunggren H.G., Karre K., Schneider G., and Sandalova T. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin. J. Mol. Biol. 356 (2006) 382-396
41. Ince M.N., Harnisch B., Xu Z., Lee S.K., Lange C., Moretta L., et al. Increased expression of the natural killer cell inhibitory receptor CD85j/ILT2 on antigen-specific effector CD8 T cells and its impact on CD8 T-cell function. Immunology 112 (2004) 531-542
42. Saverino D., Fabbi M., Ghiotto F., Merlo A., Bruno S., Zarcone D., et al. The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions. J. Immunol. 165 (2000) 3742-3755
43. Saverino D., Merlo A., Bruno S., Pistoia V., Grossi C.E., and Ciccone E. Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells. J. Immunol. 168 (2002) 207-215
44. Chapman T.L., Heikema A.P., West Jr. A.P., and Bjorkman P.J. Crystal structure and ligand binding properties of the D1D2 region of the inhibitory receptor LIR-1 (ILT2). Immunity 13 (2000) 727-736
45. Michaelsson J., Achour A., Rolle A., and Karre K. MHC class I recognition by NK receptors in the Ly49 family is strongly influenced by the beta 2-microglobulin subunit. J. Immunol. 166 (2001) 7327-7334
46. Guex N., and Peitsch M.C. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18 (1997) 2714-2723
47. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D 54 (1998) 905-921
48. Robertson M.J., Cochran K.J., Cameron C., Le J.M., Tantravahi R., and Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24 (1996) 406-415
49. Fanslow W.C., Anderson D.M., Grabstein K.H., Clark E.A., Cosman D., and Armitage R.J. Soluble forms of CD40 inhibit biologic responses of human B cells. J. Immunol. 149 (1992) 655-660
50. Gill S.C., and von Hippel P.H. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182 (1989) 319-326
51. Gill S.C., and von Hippel P.H. Errata. Anal. Biochem 189 (1990) 283